<div class="entities" style="line-height: 2.5; direction: ltr">
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    B96Bom
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 encodes a Bombyx mori 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tyramine receptor
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 negatively coupled to adenylate cyclase. A cDNA encoding a 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    biogenic amine receptor
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 (
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    B96Bom
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
) was isolated from silkworm (Bombyx mori) larvae, and the ligand response of the receptor stably expressed in 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HEK-293
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 cells was examined. Tyramine (TA) at 0.1-100 micro m reduced forskolin (10 micro m)-stimulated intracellular cAMP levels by approximately 40%. The inhibitory effect of TA at 1 micro m was abolished by yohimbine and chlorpromazine (each 10 micro m). Although 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    octopamine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 (OA) also reduced the cAMP levels, the potency was at least two orders of magnitude lower than that of TA. Furthermore, unlabelled TA (
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IC50
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 = 5.2 nm) inhibited specific [
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    3H]TA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 binding to the membranes of 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    B96Bom
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
-transfected 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    HEK-293
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 cells more potently than did OA (
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IC50
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 = 1.4 micro m) and dopamine (
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IC50
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 = 1.7 micro m). Taken together with the result of phylogenetic analysis, these findings indicate that the 
<mark class="entity" style="background: linear-gradient(90deg, #aa9cfc, #fc9ce7); padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    B96Bom
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">Gene</span>
</mark>
 receptor is a B. mori TA receptor, which is negatively coupled to adenylate cyclase. The use of this expression system should facilitate physiological studies of TA receptors as well as structure-activity studies of TA receptor ligands.</div>